Case Report
Copyright ©2010 Baishideng.
World J Hepatol. Apr 27, 2010; 2(4): 162-166
Published online Apr 27, 2010. doi: 10.4254/wjh.v2.i4.162
Table 1 Time line showing the clinical course of the patient
Period 2008-09EventHCV RNA IU/mLWBC×103/μLANC/μLHb g/dLPlatelets×103/μLALT IU/LBT mg/dLTSH IU/mLIFN dose/wkRBV dose/d
Early DecemberStart of HCV treatment4 275 0005.6360015.9NCa660.71.55180 mcg1000 mg
Early JanuaryPlatelets decreased309 2305.0230014.531571.0NA135 mcgNo change
Late JanuaryStart of neurological symptoms18 8803.9140012.745380.8NATreatment held
Mid FebruaryWorsening of symptomsNA6.4400015.161590.61.92Treatment on hold
AprilF/U visitb improvement in symptoms499 6607.2440015.894610.6NATreatment on hold
Table 2 Electromyography studies
SideMuscleNerveRootInsertional activityFibrillationsPswAmpDurPolyInterphase pattern
RightMedGastrocTibialS1-2NmlNmlNmlNmlNml0Nml
RightAntTibialisDeep br peronealL4-5NmlNmlNmlNmlNml025%
Table 3 Nerve conduction studies
Distal latency (m/s)Conduction velocity (m/s)Amplitude sensory (uV) motor (mV)
Sensory
Right radial2.8 (NML < 2.6)11 (NML > 20)
Right suralAbsentaAbsenta
Motor
Right median6.0 (NML < 4.4)37 (NML > 49)5.6 (NML > 4.2)
Right ulnar4.1 (NML < 3.5)41 (NML > 49)6.0 (NML > 5.6)
Right peroneal11.4 (NML < 5.7)0.7 (NML > 2.2)
Right tibial12.1 (NML < 5.7)1.0 (NML > 2.8)
F wave
Right median33 (NML < 31)
Right ulnar27.6 (NML < 31)
Right peronealAbsent
Right tibialAbsent